Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterization

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• Endothelial cells play a crucial role in regulating vascular function.
• Plasminogen activators are key enzymes in fibrinolysis.
• Inhibitors of plasminogen activators are important in controlling blood clot formation and degradation.

Purpose of the Study:

• To purify and characterize a plasminogen activator inhibitor from human umbilical vein endothelial cell conditioned medium.
• To investigate the inhibitor's properties and its cross-reactivity with inhibitors from other sources.
• To develop an antiserum for functional neutralization studies.

Main Methods:

• Two-step purification procedure without denaturants.
• Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for molecular mass determination.
• Antiserum generation and immunoglobulin fraction purification for neutralization assays.

Main Results:

• A single-chain glycoprotein inhibitor with an apparent molecular mass of 48 kDa was purified.
• The inhibitor exhibited specific activity (8500 U/mg protein), which increased upon denaturant treatment.
• The raised antiserum recognized plasminogen activator inhibitor from endothelial cells, platelets, and plasma.
• The immunoglobulin fraction neutralized the inhibitor's activity from all tested sources.

Conclusions:

• A novel plasminogen activator inhibitor was successfully isolated and characterized from endothelial cells.
• The inhibitor demonstrates broad specificity, acting on plasminogen activator inhibitors from various biological sources.
• The developed antiserum provides a tool for further investigation and potential therapeutic applications targeting fibrinolysis.